Tumor Size Predicts Post-Surgical Speech Difficulties in Pediatric Posterior Fossa Tumors

Overview

This prospective multicenter study demonstrates that larger posterior fossa tumor volumes, measured via semi-automated 3D segmentation, are associated with an increased risk of postoperative speech impairment (POSI) in children. Tumors involving the brainstem or fourth ventricle confer higher POSI risk compared to similarly sized tumors in other cerebellar locations.

Background

Central nervous system tumors are the most common solid tumors in children, with over half arising in the posterior fossa. Cerebellar mutism syndrome (CMS), characterized primarily by postoperative speech impairment, affects approximately 30% of pediatric posterior fossa tumor resections and can lead to long-term neurocognitive and motor deficits. While factors such as younger age, tumor pathology, and midline location have been studied as CMS risk factors, the impact of tumor size remains underexplored. Accurate 3D volumetric measurement using semi-automated segmentation tools like SmartBrush™ may improve risk stratification and surgical planning.

Data Highlights

The study prospectively included children under 18 years undergoing posterior fossa tumor resection across 29 centers in 13 countries from 2014 to 2023. Tumor volumes were measured preoperatively using semi-automated segmentation on contrast-enhanced MRI. Postoperative speech status was assessed 1–4 weeks after surgery and categorized as habitual speech, reduced speech, or mutism. Tumor location was classified into brainstem, fourth ventricle, vermis, or cerebellar hemisphere involvement. Tumor pathology was categorized into pilocytic astrocytoma, medulloblastoma, ependymoma, atypical teratoid/rhabdoid tumor, or other.

Key Findings

• Larger posterior fossa tumor volumes are significantly associated with increased risk of postoperative speech impairment in pediatric patients.
• Tumors involving the brainstem or fourth ventricle have a higher likelihood of causing POSI compared to tumors located in the vermis or cerebellar hemispheres.
• The association between tumor volume and POSI risk is stronger in high-grade tumor types such as medulloblastoma and atypical teratoid/rhabdoid tumors.
• Semi-automated 3D volumetric segmentation using SmartBrush™ provides reliable and precise tumor volume measurements, facilitating improved risk assessment.
• Postoperative speech impairment ranges from reduced speech to mutism, with mutism representing the most severe form of CMS.

Clinical Implications

Preoperative assessment of tumor volume and location using semi-automated 3D segmentation can enhance risk stratification for postoperative speech difficulties in children undergoing posterior fossa tumor resection. Awareness of higher POSI risk with larger tumors and those involving critical structures like the brainstem or fourth ventricle may guide surgical planning to minimize speech-related morbidity. Early identification of at-risk patients can also inform postoperative monitoring and rehabilitation strategies.

Conclusion

This study establishes tumor volume and anatomical involvement as important predictors of postoperative speech impairment in pediatric posterior fossa tumor surgery. Incorporating precise volumetric analysis into clinical workflows may improve outcomes by informing surgical decision-making and patient counseling.

References

1. CMS Study Design Reference [28]
2. SmartBrush™ Tool Validation [10]
3. Previous CMS Risk Factors and Tumor Size Studies [4,6,7,8,9,12,14,16,20,21,22,25,27]